Health Canada
Symbol of the Government of Canada
Skip to content | Skip to institutional links

Common menu bar links

Home > Drugs & Health Products > MedEffect Canada > Advisories, Warnings & Recalls > For Health Professionals

Institutional links

Drugs and Health Products

For Health Professionals

2008

December

arrow Association of Raptiva (efalizumab) with serious infections, including progressive multifocal leukoencephalopathy in patients with psoriasis - EMD Serono Canada Inc.
- For Health Professionals
- For the Public
Date: 2008-12-30
arrow Reports of Eye Inflammation, Endophthalmitis, and Toxic Anterior Segment Syndrome (TASS) Following Off-label Intravitreal Use of Avastin (bevacizumab)
- Hoffmann-La Roche Limited
- For Health Professionals
- For the Public
Date: 2008-12-19

arrow Health Canada Endorsed Important Safety Information on Tarceva (erlotinib) - Hoffmann-La Roche Limited
- For Health Professionals
- For the Public
Date: 2008-12-17

arrow Possible interference of icodextrin, intravenous immunoglobulins, galactose and d-xylose with certain blood glucose meters
- Notice to Hospitals
- Public Advisory
Date: 2008-12-16

arrow Urgent Medical Device Correction: Liko Uno Patient Lift - Hill-Rom
- For Health Professionals
Date: 2008-12-15

November

arrow

Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - Bayer HealthCare and Genzyme
- Notice to Hospitals
- For the Public
Date: 2008-11-21

 
arrow Important Safety Information on Argatroban - Glaxo Operations UK Limited and Shopper's Drug Mart Specialty Health Network
- Notice to Hospitals
Date: 2008-11-12

October

arrow Urgent Medical Device Recall: LifePak CR Plus and LifePak Express Defibrillators - Physio-Control, Incorporated, a division of Medtronic of Canada, Limited
- For Health Professionals
Date: 2008-10-16

arrow

Recall Notice for Teleflex Weck Brand Ligating Clips - Teleflex Medical
- For Health Professionals
Date: 2008-10-15
arrow

Important Safety Information on Tylenol with Codeine in Nursing Mothers and Ultra-Rapid Metabolizers of Codeine - Janssen-Ortho Incorporated
- For Health Professionals
- Health Canada Public Advisory
Date: 2008-10-08

August

arrow

Important safety information to users of Liko Universal SlingBar
- Notice to Hospitals
- Peridot Medical Inc.
Date: 2008-08-20
arrow

Important Safety Information on Accusol 35 Haemodialysis Solutions for Acute Renal Therapy
- Notice to Hospitals
- Edwards Lifesciences (Canada) Inc.
Date: 2008-08-19
arrow Recall Notice: damaged Curlin infusion pumps can lead to over delivery
- For Health Professionals
- Curlin Medical, Inc.
Date: 2008-08-12

arrow

Association between TORISEL (temsirolimus) concentrate for injection and hypersensitivity/infusion reactions
- For Health Professionals
- For the Public
- Wyeth Canada
Date: 2008-08-11
arrow Desmopressin nasal sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia).
- For Health Professionals
- For the Public
- Notice to Hospitals
- Apotex Inc.
Date: 2008-08-06

arrow Fatal interactions ceftriaxone-calcium
- Notice to Hospitals
Date: 2008-08-01

July

arrow Recall of All Lots of Sandoz Timolol Ophthalmic Solution (Timolol Maleate Ophthalmic Solution USP) 0.25% and 0.5%
- For Health Professionals
- Sandoz Canada.
Date: 2008-07-25

- Health Canada's Public Warning
Date: 2008-07-18
arrow Important Safety Information on ratio-Metformin 500mg lot 638812
- For Health Professionals
- ratiopharm inc.
Date: 2008-07-25
arrow DDAVP Spray (desmopressin acetate nasal spray) and DDAVP Rhinyle (desmopressin acetate nasal solution) have been associated with an increased risk of hyponatremia
- For Health Professionals
- For the Public
- Ferring Pharmaceuticals
Date: 2008-07-18

arrow Ratio-Morphine Tablets Recalled in Canada due to Risk of Accidental Overdose
- For Health Professionals
- ratiopharm inc.
Date: 2008-07-14

- Health Canada's Public Warning
Date: 2008-07-09
arrow Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma
- For the Public
- Notice to Hospitals
- Hoffmann-La Roche Limited
Date: 2008-07-10
arrow Recall of Hemodialysis Acid Concentrates
- Notice to Hospitals
- Baxter Corporation
Date: 2008-07-10

June

arrow Association of abacavir-containing medicinal products (ZIAGEN, KIVEXA and TRIZIVIR) with a potential increased risk of myocardial infarction
- For Health Professionals
- For the Public
- GlaxoSmithKline
Date: 2008-06-23

arrow

New safety information regarding Champix (varenicline tartrate)
- For Health Professionals
- For the Public
- Pfizer Canada Inc.
Date: 2008-06-20

arrow Important Safety Information on Contaminated Heparin Coated Medical Devices.
- Notice to Hospitals
Date: 2008-06-12
arrow Increased risk of marked hepatic enzyme elevations in patients taking SOMAVERT (pegvisomant) in combination with a somatostatin analogue
- For Health Professionals
- For the Public
- Pfizer Canada Inc.
Date: 2008-06-10
arrow New Safety Information Regarding Liver Injury and Hypersensitivity Associated with TYSABRI (natalizumab)
- For Health Professionals
- For the Public
- Biogen Idec Canada Inc.
Date: 2008-06-06

May

arrow Important Safety information concerning Medtronic Cardiopulmonary Bypass Devices Coated with Trillium Process using Contaminated Heparin
- Notice to Hospitals
- Medtronic of Canada Ltd.
Date: 2008-05-30
arrow Important Safety Information Concerning the Recall of Medtronic Cardiopulmonary Bypass Devices Coated with Carmeda Process using Contaminated Heparin.
- Notice to Hospitals
- Medtronic of Canada Ltd.
Date: 2008-05-30
arrow Association of Definity with Serious Adverse Cardiopulmonary Reactions
- For Health Professionals
- Bristol-Myers Squibb Medical Imaging
Date: 2008-05-28
arrow Association of Prezista (darunavir) with hepatotoxicity
- For Health Professionals
- For the Public
- Janssen-Ortho Inc.
Date:2008-05-15

March

arrow Important Safety Information on HEPARIN
- Notice to Hospitals

Further Details on Recall of Contaminated Heparin
- Information Update
Date: 2008-03-28
arrow New Safety Information for the anti-epileptic drug TEGRETOL (carbamazepine)
- For Health Professionals
- Novartis Pharmaceuticals Canada Inc.

Patients of Asian ancestry using epilepsy drug carbamazepine may be at increased risk of serious skin reactions
- Health Canada's Public Advisory
Date: 2008-03-20
arrow Risk of peripheral neuropathy in patients treated with telbivudine (SEBIVO) and interferon
- For Health Professionals
- For the Public
- Novartis Pharmaceuticals Canada Inc.
Date: 2008-03-12
arrow Reports of Hepatic Failure with EXJADE (deferasirox)
- For Health Professionals
- For the Public
- Novartis Pharmaceuticals Canada Inc.
Date: 2008-03-07

February

arrow Important Safety Information on Stryker Trident Hip Implants
- Notice to Hospitals
Date: 2008-02-13
Date Modified: 2009-06-09

Top of Page
Important Notices